Californian CRO ProTrials Research has been picked by fellow CA-based cancer biotech Calithera Biosciences to help it run an early-stage trial for its oncology…

Amsterdam-based contract drug developer Patheon has raised an eye-watering $625 million by offering 29.8 million shares at $21 a pop.

New York’s digital services provider for biopharma Medidata has posted what it is hailing as “record” numbers for the second quarter as it saw sales jump.

After a strong 6 months that has seen the best growth spurt in its history, Lonza is raising its guidance for the rest of the year.

CRO giant Parexel has seen its chief financial officer and senior vice president Ingo Bank resign from the company over the weekend, according to a SEC filing.

A new paper published in the journal Computer argues that personal health information must be better secured with increased privacy settings--or risk PHI…

The personal genome company 23andMe has launched a new platform that will allow researchers to see and track certain genetic information from patients in their…

Israeli biotech Pluristem Therapeutics has chosen a “leading, global” CRO to help run its Phase I blood cancer trial--but the company is a little shy on…